We spoke with Dr. Gerald Falchook about the first human study of a first-in-class molecule, fatty acid synthase inhibitor known as TVB-2640 for advanced solid tumors.
Gerald S. Falchook, MD
Advertisement
Articles by Gerald S. Falchook, MD
Advertisement
Latest Updated Articles
First Human Study Taking Place With Fatty Acid Synthase InhibitorPublished: April 7th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Durvalumab Plus Concurrent CRT Does Not Add Benefit in Stage III NSCLC
2
Radiotherapy Plus Chemoimmunotherapy Improves Frontline ES-SCLC Prognosis
3
Novel SSTR-Targeted Alpha Therapy Shows “Encouraging” Activity in GEP-NETs
4
Matched donor allogeneic CAR T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion
5
